Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Arcutis begins phase IIb portion of phase I/IIb study of ARQ-252 for chronic hand eczema

July 14, 2020

Kymera and Sanofi partner on IRAK4 protein degraders in inflammation and immunology

July 10, 2020

InMed begins second phase I trial of INM-755 for epidermolysis bullosa

July 8, 2020

Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris

July 7, 2020

New phase II trial evaluates CBP-201 for moderate to severe atopic dermatitis

July 6, 2020

Akeso begins first-in-human study of AK-120 for atopic dermatitis

July 2, 2020

Amniox begins first phase III trial of TTAX-01 in diabetic foot ulcers

July 1, 2020

Ilumya approved in Japan for plaque psoriasis

July 1, 2020

FDA approves IND for SFA-002 study in psoriasis

July 1, 2020

AOBiome begins phase IIb study with B-244 for pruritus in atopic dermatitis

June 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...